SOD1 and metabolic dysfunction-associated steatohepatitis: Koruk et al. in 2004 showed that serum levels of malondialdehyde (MDA), GSH, and SOD were higher in NASH patients than in the control group, suggesting that the antioxidant system has a key role in NAFLD pathogenesis and disease progression [86].